Ravi Karra

Conference European Heart Journal · October 28, 2024 AbstractBackgroundA subset of advanced heart failure (HF) patients can experience significant improvement in their cardiac structure a ... Full text Cite

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling

Conference JOURNAL OF HEART AND LUNG TRANSPLANTATION · April 2024 Link to item Cite

Combined Usage Of CMRI And The Madrid Genotype Score To Identify Genetic Cardiomyopathies

Conference JOURNAL OF CARDIAC FAILURE · January 2024 Link to item Cite

Abstract 17139: Angiopoietin 2 Independently Predicts Heart Failure Hospitalization and is Beneficially Modified by GLP1RA: Results From the EXSCEL Trial

Conference Circulation · November 7, 2023 Background: Higher plasma concentrations of angiopoietin 2 (ANGPT2) are associated with higher risk for hospitalization for heart failure (HF) and death in univariate analyses. However, the independen ... Full text Cite

Multicenter Transthyretin Cardiac Amyloidosis Study Demonstrates Differences In Phenotype And Outcomes By Race

Conference JOURNAL OF CARDIAC FAILURE · April 2023 Link to item Cite

Atrial Fibrillation And Conduction Disease Are Associated With Cardiac Amyloidosis Subtypes

Conference JOURNAL OF CARDIAC FAILURE · April 2023 Link to item Cite

MIMICKING THE GREAT MIMICKER: LMNA CARDIOMYOPATHY PRESENTING AS ISOLATED CARDIAC SARCOIDOSIS

Conference Journal of the American College of Cardiology · March 2023 Full text Cite

Angiopoetin 2 Predicts Clinical Outcomes And Recovery Of Ventricular Function In Heart Failure

Conference JOURNAL OF CARDIAC FAILURE · April 2022 Link to item Cite

TIME TO RELAPSE AFTER WEANING IMMUNE SUPPRESSIVE THERAPY IN CARDIAC SARCOIDOSIS: A SINGLE-CENTER EXPERIENCE

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 8, 2022 Link to item Cite

Evaluating the effect of longitudinal dose and INR data on maintenance warfarin dose predictions

Conference Bhi 2021 2021 IEEE EMBS International Conference on Biomedical and Health Informatics Proceedings · January 1, 2021 Warfarin, a commonly prescribed drug to prevent blood clots, has a highly variable individual response. Determining a maintenance warfarin dose that achieves a therapeutic blood clotting time, as measured by the international normalized ratio (INR), is cru ... Full text Cite

Heart Sound Analysis in Individuals Supported with Left Ventricular Assist Device: A First Look

Conference Computing in Cardiology · September 13, 2020 The left ventricular assist device (LVAD) has emerged as a bridge or alternative to heart transplant in individuals with advanced heart failure. However, the LVAD recipient population currently faces high rehospitalization rates. Remote analysis of precord ... Full text Cite

HEMODYNAMIC EFFECTS OF NITROXYL DONOR BMS-986231 COMPARED TO NITROGLYCERIN OR PLACEBO IN PATIENTS WITH CHRONIC HEART FAILURE-A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 24, 2020 Link to item Cite

Reduced Gastrointestinal Bleeding in Patients With Improved Left Ventricular Function After Left Ventricular Assist Device Implantation

Conference CIRCULATION · November 6, 2018 Link to item Cite

Convergence of genome-wide expression analysis and genome-wide linkage analysis identifies candidate genes for atherosclerosis

Conference CIRCULATION · October 26, 2004 Link to item Cite

Genomic convergence in the study of human and mouse atherosclerosis

Conference CIRCULATION · October 28, 2003 Link to item Cite

Ravi Karra

Scholarly Works - Conferences

Outcomes Following HeartMate 3 Left Ventricular Assist Device (LVAD) Exchange for Complex LVAD-Specific Infection

Plasma Adenosine Deaminase 2 as a Potential Disease Activity Biomarker for Sarcoidosis

A gene regulatory element modulates myosin expression and alters cellular stress response

Derivation and validation of a multicenter model to identify candidates for advanced HF therapies with high potential to achieve post-LVAD reverse cardiac remodeling